Dr. Robert V. Dimeglio, M.D.
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Emory University School of Medicine (1991)
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 434
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1991Medical school: Emory University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
GA license 042231
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northside Hospital Atlanta, GA
- Piedmont Hospital, Inc Atlanta, GA
- Piedmont Newnan Hospital, Inc Newnan, GA
Medical groups
- Georgia Urology, PA (103 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 434
- Services billed
- 2,360
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Automated urinalysis test | 672 | 369 |
| Established patient office or other outpatient visit, 30-39 minutes | 403 | 265 |
| Established patient office or other outpatient visit, 20-29 minutes | 171 | 113 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 90 | 12 |
| New patient office or other outpatient visit, 45-59 minutes | 78 | 78 |
| Diagnostic exam of bladder and urethra using an endoscope | 63 | 55 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 34 | 13 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 30 | 12 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Atlanta, GA | 521 |
| Finasteride Other prescribers in Atlanta, GA | 406 |
| Dutasteride Other prescribers in Atlanta, GA | 101 |
| Nitrofurantoin (nitrofurantoin macrocrystal) Other prescribers in Atlanta, GA | 86 |
| Ciprofloxacin Hcl Other prescribers in Atlanta, GA | 66 |
| Gemtesa (vibegron) Other prescribers in Atlanta, GA | 53 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Atlanta, GA | 45 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Atlanta, GA | 42 |
| Testosterone Cypionate Other prescribers in Atlanta, GA | 42 |
| Amoxicillin Other prescribers in Atlanta, GA | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 28 payments worth $682 in total to this clinician.
| Janssen Biotech, Inc. | $93.31 |
|---|---|
| Sumitomo Pharma America, Inc. | $92.51 |
| Ferring Pharmaceuticals Inc. | $91.34 |
| Medtronic, Inc. | $66.17 |
| Urogen Pharma, Inc. | $43.55 |
| Bayer HealthCare Pharmaceuticals Inc. | $42.01 |
| AstraZeneca Pharmaceuticals LP | $35.06 |
| Tolmar, Inc. | $30.48 |
| Food and Beverage | $647 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 23, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.